Barlati S - Search Results

1

Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells.

Salvi A, Arici B, De Petro G, Barlati S. Salvi A, et al. Among authors: barlati s. Mol Cancer Ther. 2004 Jun;3(6):671-8. Mol Cancer Ther. 2004. PMID: 15210852

2

In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.

Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S. Salvi A, et al. Among authors: barlati s. Int J Oncol. 2007 Aug;31(2):451-60. Int J Oncol. 2007. PMID: 17611703

3

Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.

Salvi A, Bongarzone I, Miccichè F, Arici B, Barlati S, De Petro G. Salvi A, et al. Among authors: barlati s. Neoplasia. 2009 Feb;11(2):207-19. doi: 10.1593/neo.81076. Neoplasia. 2009. PMID: 19177205 Free PMC article.

4

MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S. Salvi A, et al. Among authors: barlati s. FEBS J. 2009 Jun;276(11):2966-82. doi: 10.1111/j.1742-4658.2009.07014.x. Epub 2009 Apr 16. FEBS J. 2009. PMID: 19490101 Free article.

5

Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.

Salvi A, Conde I, Abeni E, Arici B, Grossi I, Specchia C, Portolani N, Barlati S, De Petro G. Salvi A, et al. Among authors: barlati s. Mol Cancer. 2013 Dec 13;12:162. doi: 10.1186/1476-4598-12-162. Mol Cancer. 2013. PMID: 24330766 Free PMC article.

6

Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.

Tavian D, Salvi A, De Petro G, Barlati S. Tavian D, et al. Among authors: barlati s. Cancer Gene Ther. 2003 Feb;10(2):112-20. doi: 10.1038/sj.cgt.7700533. Cancer Gene Ther. 2003. PMID: 12536199

7

Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.

De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S. De Petro G, et al. Among authors: barlati s. Cancer Res. 1998 May 15;58(10):2234-9. Cancer Res. 1998. PMID: 9605771

8

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.

Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM, Barlati S. Tavian D, et al. Among authors: barlati s. Int J Cancer. 2000 Sep 1;87(5):644-9. Int J Cancer. 2000. PMID: 10925356

9

RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice.

Salvi A, Arici B, Alghisi A, Barlati S, De Petro G. Salvi A, et al. Among authors: barlati s. Tumour Biol. 2007;28(1):16-26. doi: 10.1159/000097699. Epub 2006 Dec 5. Tumour Biol. 2007. PMID: 17159381

10

The FN13 peptide inhibits human tumor cells invasion through the modulation of alpha v beta 3 integrins organization and the inactivation of ILK pathway.

Zoppi N, Ritelli M, Salvi A, Colombi M, Barlati S. Zoppi N, et al. Among authors: barlati s. Biochim Biophys Acta. 2007 Jun;1773(6):747-63. doi: 10.1016/j.bbamcr.2007.02.007. Epub 2007 Feb 24. Biochim Biophys Acta. 2007. PMID: 17383746 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters